Global testing of a consensus solubility assessment to enhance robustness of the WHO biopharmaceutical classification system

The WHO Biopharmaceutical Classification System (BCS) is a practical tool to identify active pharmaceutical ingredients (APIs) that scientifically qualify for a waiver of in vivo bioequivalence studies. The focus of this study was to engage a global network of laboratories to experimentally quantify...

Descripción completa

Detalles Bibliográficos
Autores principales: Gigante, Valeria, Pauletti, Giovanni M., Kopp, Sabine, Xu, Minghze, Gonzalez-Alvarez, Isabel, Merino, Virginia, McIntosh, Michelle P., Wessels, Anita, Lee, Beom-Jin, Rezende, Kênnia Rocha, Scriba, Gerhard K.E., Jadaun, Gaurav P.S., Bermejo, Marival
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Association of Physical Chemists 2020
Materias:
Original Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923308/
https://www.ncbi.nlm.nih.gov/pubmed/35299876
http://dx.doi.org/10.5599/admet.850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923308/
https://www.ncbi.nlm.nih.gov/pubmed/35299876
http://dx.doi.org/10.5599/admet.850

Ejemplares similares